A detailed history of Principal Financial Group Inc transactions in Fibrogen Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 21,940 shares of FGEN stock, worth $19,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,940
Previous 24,499 10.45%
Holding current value
$19,526
Previous $21,000 142.86%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$0.73 - $2.73 $1,868 - $6,986
-2,559 Reduced 10.45%
21,940 $51,000
Q4 2023

Feb 07, 2024

SELL
$0.38 - $0.91 $470 - $1,125
-1,237 Reduced 4.81%
24,499 $21,000
Q3 2023

Nov 02, 2023

BUY
$0.79 - $2.83 $2,942 - $10,541
3,725 Added 16.92%
25,736 $22,000
Q2 2023

Aug 07, 2023

SELL
$2.49 - $20.59 $3,413 - $28,228
-1,371 Reduced 5.86%
22,011 $59,000
Q1 2023

May 09, 2023

SELL
$15.95 - $25.18 $14,769 - $23,316
-926 Reduced 3.81%
23,382 $436,000
Q4 2022

Feb 09, 2023

BUY
$13.27 - $17.73 $16,215 - $21,666
1,222 Added 5.29%
24,308 $389,000
Q3 2022

Nov 09, 2022

BUY
$11.4 - $14.6 $535 - $686
47 Added 0.2%
23,086 $300,000
Q2 2022

Aug 10, 2022

SELL
$7.94 - $12.96 $19,500 - $31,829
-2,456 Reduced 9.63%
23,039 $243,000
Q1 2022

May 09, 2022

BUY
$12.02 - $16.79 $5,204 - $7,270
433 Added 1.73%
25,495 $306,000
Q4 2021

Feb 09, 2022

SELL
$9.93 - $15.39 $100,809 - $156,239
-10,152 Reduced 28.83%
25,062 $353,000
Q3 2021

Nov 09, 2021

BUY
$10.18 - $26.64 $7,787 - $20,379
765 Added 2.22%
35,214 $360,000
Q2 2021

Aug 10, 2021

SELL
$18.57 - $35.68 $5.67 Million - $10.9 Million
-305,273 Reduced 89.86%
34,449 $917,000
Q1 2021

May 10, 2021

BUY
$31.0 - $55.72 $1.9 Million - $3.42 Million
61,374 Added 22.05%
339,722 $11.8 Million
Q4 2020

Feb 08, 2021

BUY
$37.09 - $48.97 $497,710 - $657,128
13,419 Added 5.07%
278,348 $10.3 Million
Q3 2020

Nov 06, 2020

BUY
$40.47 - $45.5 $103,158 - $115,979
2,549 Added 0.97%
264,929 $10.9 Million
Q2 2020

Aug 05, 2020

BUY
$32.57 - $42.83 $3.05 Million - $4.01 Million
93,649 Added 55.5%
262,380 $10.6 Million
Q1 2020

May 12, 2020

BUY
$23.3 - $45.96 $140,662 - $277,460
6,037 Added 3.71%
168,731 $5.86 Million
Q4 2019

Feb 05, 2020

SELL
$34.58 - $48.06 $80,398 - $111,739
-2,325 Reduced 1.41%
162,694 $6.98 Million
Q3 2019

Nov 13, 2019

SELL
$36.98 - $48.45 $73,220 - $95,931
-1,980 Reduced 1.19%
165,019 $6.1 Million
Q2 2019

Aug 12, 2019

BUY
$35.13 - $55.53 $847,792 - $1.34 Million
24,133 Added 16.89%
166,999 $7.55 Million
Q1 2019

May 10, 2019

BUY
$42.83 - $59.91 $177,915 - $248,866
4,154 Added 2.99%
142,866 $7.77 Million
Q4 2018

Feb 14, 2019

SELL
$37.97 - $60.16 $481,269 - $762,528
-12,675 Reduced 8.37%
138,712 $6.42 Million
Q3 2018

Nov 14, 2018

BUY
$56.3 - $67.25 $213,320 - $254,810
3,789 Added 2.57%
151,387 $9.2 Million
Q2 2018

Aug 13, 2018

BUY
$44.9 - $64.95 $1.1 Million - $1.59 Million
24,423 Added 19.83%
147,598 $0
Q1 2018

May 14, 2018

SELL
$45.35 - $61.65 $67,027 - $91,118
-1,478 Reduced 1.19%
123,175 $5.69 Million
Q4 2017

Feb 13, 2018

SELL
$41.95 - $60.1 $339,878 - $486,930
-8,102 Reduced 6.1%
124,653 $5.91 Million
Q3 2017

Nov 02, 2017

BUY
$33.4 - $53.9 $4.43 Million - $7.16 Million
132,755
132,755 $7.14 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $83.4M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.